PKC-PKD-NFκB signalling induces cardiomyocyte t-tubule loss via a conserved macropinocytic mechanism

A Martinez-Vilchez1, A-K M Pfeuffer1, J Weßolowski1

  • 1Institute of Cellular and Molecular Physiology, Friedrich-Alexander-University Erlangen-Nürnberg, Waldstr. 6, 91054 Erlangen, Germany.

Abstract

Insights

Protein kinase C (PKC) activation triggers cardiomyocyte t-tubule loss via a macropinocytic process involving protein kinase D (PKD) and NFκB signaling. Targeting this pathway may preserve cardiac function in heart failure.

Area of Science:

  • Cardiology
  • Cell Biology
  • Molecular Biology

Background:

  • Transverse-axial tubule (t-tubule) integrity is crucial for cardiac excitation-contraction coupling.
  • T-tubule deterioration contributes to heart failure, but underlying mechanisms are poorly understood.

Purpose of the Study:

  • To identify signaling pathways and cellular processes responsible for cardiomyocyte t-tubule loss.
  • To elucidate the role of protein kinase C (PKC) in t-tubule remodeling.

Main Methods:

  • Utilized adult rat, rabbit, and human ventricular cardiomyocytes and myocardial slices.
  • Applied pharmacological activators/inhibitors of PKC, protein kinase D (PKD), and NFκB.
  • Conducted RNA-sequencing, phosphoprotein analysis, and fluorescent dextran uptake assays.
  • Investigated t-tubule density in cardiomyocytes from transgenic mice with constitutive IKK2 activation.

Main Results:

  • PKC activation induced rapid t-tubule loss and impaired Ca²⁺ transients in cardiomyocytes.
  • PKC-induced effects were prevented by inhibiting PKD or NFκB.
  • PKD, ERK, and NFκB pathways were activated, with increased expression of genes related to membrane trafficking and endocytosis.
  • A clathrin-independent, PI3K- and myosin-I-dependent macropinocytic process was identified as the mechanism for t-tubule membrane internalization, blocked by NFκB inhibition.
  • Constitutive NFκB activation in mice reduced t-tubule density in vivo.
  • NFκB inhibition blocked PKC-induced macropinocytosis in non-cardiac cell lines, indicating a conserved response.

Conclusions:

  • PKC-PKD-NFκB signaling drives a macropinocytic membrane remodeling process that degrades the t-tubule network.
  • This mechanism links inflammatory kinase activation to cardiomyocyte structural and functional decline.
  • Targeting the PKD-NFκB axis offers a potential strategy to preserve t-tubule integrity and cardiac performance in heart failure.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...